DAVENPORT & Co LLC Has $467,000 Holdings in Omega Healthcare Investors, Inc. $OHI

DAVENPORT & Co LLC raised its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 10.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,740 shares of the real estate investment trust’s stock after purchasing an additional 1,197 shares during the period. DAVENPORT & Co LLC’s holdings in Omega Healthcare Investors were worth $467,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Pallas Capital Advisors LLC lifted its position in Omega Healthcare Investors by 59.0% during the 2nd quarter. Pallas Capital Advisors LLC now owns 11,915 shares of the real estate investment trust’s stock valued at $437,000 after purchasing an additional 4,420 shares during the period. PFG Investments LLC lifted its position in Omega Healthcare Investors by 20.4% during the 1st quarter. PFG Investments LLC now owns 70,762 shares of the real estate investment trust’s stock valued at $2,695,000 after purchasing an additional 11,970 shares during the period. Columbus Macro LLC acquired a new position in Omega Healthcare Investors during the 1st quarter valued at about $6,353,000. Asset Management One Co. Ltd. lifted its position in Omega Healthcare Investors by 5.0% during the 1st quarter. Asset Management One Co. Ltd. now owns 514,967 shares of the real estate investment trust’s stock valued at $19,610,000 after purchasing an additional 24,640 shares during the period. Finally, Pinion Investment Advisors LLC lifted its position in Omega Healthcare Investors by 113.0% during the 1st quarter. Pinion Investment Advisors LLC now owns 38,190 shares of the real estate investment trust’s stock valued at $1,454,000 after purchasing an additional 20,262 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Mizuho upped their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Raymond James Financial reaffirmed an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Truist Financial upped their price target on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research note on Wednesday, September 3rd. Scotiabank upped their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research note on Thursday, August 28th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $44.44.

Insider Buying and Selling at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director directly owned 18,654 shares of the company’s stock, valued at $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is owned by corporate insiders.

Omega Healthcare Investors Price Performance

NYSE OHI opened at $39.83 on Monday. The business has a 50 day simple moving average of $41.57 and a 200 day simple moving average of $38.82. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $44.42. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. The stock has a market cap of $11.75 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 1.86 and a beta of 0.70.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. The business had revenue of $235.60 million during the quarter, compared to analysts’ expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.Omega Healthcare Investors’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.7%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 165.43%.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.